home.social

#biotechnology — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #biotechnology, aggregated by home.social.

  1. Korea University Study Uncovers How mRNA Vaccination May Broaden Flu Antibody Responses

    New study finds that mRNA vaccination sustained influenza-specific germinal-center activity for up to six months in some participants…
    #EuropeSays #Korea #KR #Biotechnology #ClinicalTrials&MedicalDiscoveries #HealthCare&Hospitals #InfectionControl #KoreaUniversityCollegeofMedicine #MedicalEquipment #MedicalPharmaceuticals #Pharmaceuticals #PollsandResearch #publicsafety #Surveys
    europesays.com/korea/151333/

  2. 🔬 Is it time to challenge the single-target mindset in exosome research?

    🔗 Engineering Magnetic Beads for Affinity Enrichment of Exosomes. Computational and Structural Biotechnology Journal (CSBJ). DOI: doi.org/10.34133/csbj.0170

    📚 CSBJ - A Science Partner Journal: spj.science.org/journal/csbj

    #Exosomes #ExtracellularVesicles #Biotechnology #MagneticBeads #Bioengineering #Diagnostics #Nanobiotechnology #Biomarkers #DrugDelivery #PrecisionMedicine

  3. 🧬 AOD-9604: What Does the Research Say?

    AOD-9604 is a synthetic peptide derived from a fragment of human growth hormone (176–191). It has been studied in peptide research for its potential role in fat metabolism and body composition without producing the same biological effects as full growth hormone.

    What peptide should we explore next?

    #PeptideResearch #AOD9604 #Biotechnology #ResearchOnly #MetabolicResearch #LifeScience #ScientificResearch #Peptides

  4. 🧬 PT-141 (Bremelanotide): What Does the Research Show?

    PT-141, also known as bremelanotide, is a synthetic peptide that acts on melanocortin receptors in the central nervous system. Unlike many peptides discussed in fitness and recovery research, PT-141 has primarily been studied in relation to sexual desire and arousal.

    What peptide should we break down next?

    #PeptideResearch #Bremelanotide #PT141 #Biotechnology #Biotech #ScientificResearch #Peptides #ResearchOnly

  5. 🧬 TB-500: Understanding the Science

    TB-500 is commonly discussed in peptide research because of its relationship to thymosin beta-4, a naturally occurring peptide involved in cellular processes such as cell migration and tissue organization.

    Which peptide should we break down next?

    #PeptideResearch #Biotechnology #Biotech #ScientificResearch #Peptides #ResearchOnly #LifeScience #MolecularBiology

  6. Alvotech gets FDA VAI classification for Iceland plant | ALVO SEC Filing

    UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16…
    #Iceland #IS #Europe #Europa #EU #ALVO #Alvotech #AVT05 #AVT06 #AVT16 #biosimilars #Biotechnology #BLA #FDAInspection #iceland #island #VAIclassification
    europesays.com/3162739/

  7. 🧬 As biodiversity faces unprecedented challenges, high-quality reference #genomes preserve invaluable biological knowledge for future generations. Together, EBP affiliates are building the genomic foundation for #discoveries in #evolution, #conservation, agriculture, #biotechnology, and beyond.

  8. Colossal Biosciences Is Making Jurassic Park Look Like a Pitch Deck

    Modern biotechnology labs are driving advances in gene editing and de-extinction research

    Dear Cherubs, Dallas has apparently decided extinction is just a product category. Colossal Biosciences is now a billionaire-level biotech spectacle, with the company saying its latest Series C brought total funding to $615 million and ABC News reporting a roster of celebrity backers that includes Tom Brady, Tiger Woods, Paris Hilton and Peter Jackson. Dallas Innovates also reported that the CIA’s venture arm, In-Q-Tel, invested in Colossal back in 2022.

    The result is a company that sounds like it was brainstormed by a film studio, a venture fund and a very committed science teacher. Colossal says it is working on de-extinction projects tied to the woolly mammoth, dodo, thylacine and dire wolf, using gene editing, synthetic biology and related conservation tools. So no, this is not literally Jurassic Park; it is more like Jurassic Park after legal review and a lot of grant money.

    THE TEA, BUT WITH MICROPIPETTES

    In April, Reuters reported that Colossal announced three genetically engineered wolf pups and called them the world’s first successfully “de-extincted” animals, while outside experts were more cautious and described them as genetically modified gray wolves with added dire-wolf traits. ABC News said Colossal edited gray wolf cells at multiple sites and noted the two species are about 99.5% genetically identical, which is a very impressive number and also a reminder that biology is rude and complicated.

    That is the key detail the movie version never pauses for: the company is not dusting off a frozen dinosaur and pressing play. It is using ancient DNA, gene editing and surrogate biology to create something that resembles an extinct species closely enough to trigger headlines, debates and a healthy amount of side-eye. The label “de-extincted” is doing a lot of heavy lifting here.

    WHY THE MONEY FLOWS

    The money makes more sense when you look at the technology stack. Dallas Innovates reported that In-Q-Tel said its interest in Colossal was “less about the mammoths and more about the capability,” while Colossal’s own materials say the work could scale CRISPR, synthetic biology, artificial wombs and genomic preservation platforms. In other words, the extinct-animal angle is the headline; the platform is the business.

    Colossal has also built a pop-culture-friendly halo around the science. Its advisory board page lists Tom Brady and George R.R. Martin among its cultural advisors, which is exactly the kind of sentence that makes the internet stop scrolling for a second. That is the trick here: make de-extinction feel part science, part blockbuster, part meme, and suddenly the cap table looks almost inevitable.

    The hot take is simple: this is not a cartoonish clone factory, and it is not pure hype either. It is a very expensive attempt to push gene editing, cloning-adjacent methods and reproductive tech into territory that could one day matter for conservation as much as spectacle. The dinosaurs are still fiction, but the lab bills are extremely real.

    Sources list
    ABC News — https://abcnews.go.com/US/dire-wolf-revived-biotech-companys-de-extinction-process/story?id=120558562
    Reuters — https://www.reuters.com/science/us-company-resurrects-extinct-dire-wolf-or-some-version-it-2025-04-08/
    Dallas Innovates — https://dallasinnovates.com/mammoth-interest-the-cia-invests-in-dallas-based-colossal-biosciences/
    Colossal Biosciences — https://colossal.com/colossal-secures-200m-to-accelerate-de-extinction-and-genomic-innovation/
    Colossal Biosciences — https://colossal.com/advisors/
    Wikimedia Commons (Laboratory.jpg) — https://commons.wikimedia.org/wiki/File:Laboratory.jpg

    The Thisclaimer logo blends a classic warning symbol with a brain icon to represent critical thinking, curiosity, and thoughtful disclaimers. #animals #biotechnology #cia #colossalBiosciences #crispr #deExtinction #direWolf #geneEditing #inQTel #nature #news #science #syntheticBiology #texasStartup
  9. 3 gene editing technologies transforming biology 🧬

    CRISPR-Cas9: targeted cutting → knockout or insertion

    Base editing: single-nucleotide changes, no double-strand breaks  

    Prime editing: insert, delete, or replace sequences with precision

    For aging research: correcting genetic changes, enhancing repair, engineering resilience

    #CRISPR #GeneEditing #Biotechnology #AgingResearch #PrecisionMedicine

  10. Researchers reproduced the simplest natural #circadian system found in blue-green algae (#cyanobacteria ) within a test tube, demonstrating how a single clock signal coordinates daily #gene switching.
    #MolecularBiology #Biotechnology #Chronobiology #sflorg
    sflorg.com/2026/02/mbio0210260

  11. How I Built a Machine Learning Tool to Predict Drug Manufacturing Failures

    A bioprocess engineer's journey into machine learning and why the pharmaceutical industry desperately needs this bridge When I tell people I work in bioprocess engineering, I usually get blank stares. When I explain that I help manufacture proteins in giant tanks for therapeutic use, the response is often: "Oh, like brewing beer?" Not quite. But close enough. What I don't usually mention is that I've been teaching myself machine learning on nights and weekends. Not because it's trendy, but […]

    kemal.yaylali.uk/from-bioreact

  12. #Cyanobacteria are key #ecological players of global carbon and nitrogen cycles. They are also becoming increasingly important for carbon-neutral biotechnology. They could serve as green cell factories for a light-driven and sustainable production of #chemicals and #fuels
    #Biotechnology #Microbiology #MolecularBiology #sflorg
    sflorg.com/2026/01/btech011426

  13. 🐛 Silkworm's Liquid Moonlight: From Egg to Golden Thread

    A single caterpillar spins hundreds of meters of silk in one continuous strand. For thousands of years, feeding exclusively on mulberry leaves, they spin lustrous threads that defined ancient luxury and now enable modern medical innovations.

    ✍️ Their full story: TPC8.short.gy/sJNS1j5J

    🧵 Ancient partnership, endless possibilities

    #Silk #Silkworm #Nature #Science #History #Biotechnology #Textiles #Innovation #Mulberry #Biodiversity #TPC8

  14. 🐛 The Silkworm's Liquid Moonlight: From Tiny Egg to Golden Thread

    A single caterpillar spins hundreds of meters of silk in one continuous strand. For 5,000 years, these remarkable creatures have transformed mulberry leaves into threads that built empires and now inspire medical breakthroughs.

    ✍️ Their full story here: TPC8.short.gy/sJNS1j5J

    🧵 Ancient partnership, endless possibilities

    #Silk #Silkworm #Nature #Science #History #Biotechnology #Textiles #Innovation #Mulberry #Biodiversity #TPC8

  15. 🐛 The Silkworm's Liquid Moonlight: From Tiny Egg to Golden Thread

    A single caterpillar spins hundreds of meters of silk in one continuous strand. For 5,000 years, these remarkable creatures have transformed mulberry leaves into threads that built empires and now inspire medical breakthroughs.

    ✍️ Their full story here: TPC8.short.gy/sJNS1j5J

    🧵 Ancient partnership, endless possibilities

    #Silk #Silkworm #Nature #Science #History #Biotechnology #Textiles #Innovation #Mulberry #Biodiversity #TPC8

  16. 🐛 Silkworm's Liquid Moonlight: From Egg to Golden Thread

    A single caterpillar spins hundreds of meters of silk in one continuous strand. For thousands of years, feeding exclusively on mulberry leaves, they spin lustrous threads that defined ancient luxury and now enable modern medical innovations.

    ✍️ Their full story: TPC8.short.gy/sJNS1j5J

    🧵 Ancient partnership, endless possibilities

    #Silk #Silkworm #Nature #Science #History #Biotechnology #Textiles #Innovation #Mulberry #Biodiversity #TPC8

  17. 🐛 Silkworm's Liquid Moonlight: From Egg to Golden Thread

    A single caterpillar spins hundreds of meters of silk in one continuous strand. For thousands of years, feeding exclusively on mulberry leaves, they spin lustrous threads that defined ancient luxury and now enable modern medical innovations.

    ✍️ Their full story: TPC8.short.gy/sJNS1j5J

    🧵 Ancient partnership, endless possibilities

    #Silk #Silkworm #Nature #Science #History #Biotechnology #Textiles #Innovation #Mulberry #Biodiversity #TPC8

  18. Thursday, September 4, 2025

    Ukraine destroys Russian speedboat as it attempts to land troops, Navy says, shares footage -- Behind Ukraine’s manpower crisis lies a bleak new battlefield reality for infantry -- Fears of Russian hit campaign grow as another nationalist politician is murdered in Ukraine -- No regional centers captured, 1 million dead Russian soldiers — Ukrainian official responds to Putin's threats with list of Russia's military achievements ... and more

    activitypub.writeworks.uk/2025

  19. AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  20. AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  21. AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  22. AstraZeneca to pay Pfizer $107.5M in damages in Tagrisso patent tussle—FDA approves two biosimilars to blockbuster eye drug Eylea —Why AlphaFold 3 is stirring up so much buzz in pharma --bit.ly/w28kSd #astrazeneca #pfizer #patents #legal #biosimilars #fda #eylea #ai #googledeepmind #drugdevelopment #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  23. AstraZeneca to pay Pfizer $107.5M in damages in Tagrisso patent tussle—FDA approves two biosimilars to blockbuster eye drug Eylea —Why AlphaFold 3 is stirring up so much buzz in pharma --bit.ly/w28kSd #astrazeneca #pfizer #patents #legal #biosimilars #fda #eylea #ai #googledeepmind #drugdevelopment #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  24. AstraZeneca to pay Pfizer $107.5M in damages in Tagrisso patent tussle—FDA approves two biosimilars to blockbuster eye drug Eylea —Why AlphaFold 3 is stirring up so much buzz in pharma --bit.ly/w28kSd #astrazeneca #pfizer #patents #legal #biosimilars #fda #eylea #ai #googledeepmind #drugdevelopment #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  25. J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales—Humira biosimilar scripts take off—Intra-Cellular launches 26% to record high, breaking out after depression drug scores big--bit.ly/w28kSd #earnings #jnj #abbvie #humira #biosimilars #depression #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  26. 5 successful phase III oncology trials in Q1—FDA gives nod to BrainStorm for ALS trial after Phase III flop—AbbVie’s Humira loses only 4% of market share to biosimilars--bit.ly/w28kSd #clinicaltrials #oncology #fda #als #abbvie #humira #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  27. Could pharma’s legal attack on the IRA succeed in killing price negotiations?—Gilead tries new triple-target T-cell engagers in $1.5B-plus Merus collab—Sandoz nabs FDA approvals for first two biosimilars for Amgen’s denosumab--bit.ly/w28kSd #inflationreductionact #medicare #drugpricing #gileadsciences #sandoz #biosimilars #amgen #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  28. Could pharma’s legal attack on the IRA succeed in killing price negotiations?—Gilead tries new triple-target T-cell engagers in $1.5B-plus Merus collab—Sandoz nabs FDA approvals for first two biosimilars for Amgen’s denosumab--bit.ly/w28kSd #inflationreductionact #medicare #drugpricing #gileadsciences #sandoz #biosimilars #amgen #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  29. Moderna posts surprise quarterly profit as it eyes RSV vaccine approval —Samsung joins biosimilar race for Merck & Co.'s Keytruda blockbuster—Zimmer receives FDA clearance for robotic shoulder system--bit.ly/w28kSd #moderna #rsv #vaccines #merck #samsung #biosimilars #keytruda #roboticsurgery #zimmerbiomet #fda #shoulderreplacement #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  30. AbbVie’s Humira maintains market dominance amid biosimilar launches —Bayer CEO Bill Anderson makes his mark with major restructuring, 'significant' job cuts — Novartis ends phase III peanut allergy trial --bit.ly/w28kSd #biosimilars #humira #abbvie #bayer #restructuring #layoffs #novartis #clinicaltrials #peanutallergy #novartis #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  31. The developer of an experimental immunotherapy delivering nanoscale payloads to treat pancreatic cancer says the treatment received fast-track status from the Food and Drug Administration.

    sciencebusiness.technewslit.co

    #News #Press #Science #Business #Cancer #FDA #Biotechnology #PancreaticCancer #Tumor #Immunotherapy #FastTrack #ClinicalTrial #Nanoscale #Antibody #Australia